Letter: The Role of Medical Treatment on Outcomes After Endovascular Revascularization of Infrainguinal Peripheral Artery Disease

Abstract

Keywords

peripheral arterial disease SGLT-2 inhibitors cilostazol statin

Get full access to this article

View all access options for this article.

References

Korosoglou

Feld

Langhoff

Lichtenberg

Stausberg

Hoffmann

, et al. RECCORD Investigators Safety and effectiveness of debulking for the treatment of infrainguinal peripheral artery disease. Data from the Recording Courses of vascular Diseases Registry in 2910 patients. Angiology. 2025; 76(10): 981-990.

Jansen-Chaparro

López-Carmona

Cobos-Palacios

Sanz-Cánovas

Bernal-López

Gómez-Huelgas

. Statins and peripheral arterial disease: a narrative review. Front Cardiovasc Med 2021; 8: 777016.

Visseren

FLJ

Mach

Smulders

Carballo

Koskinas

Bäck

, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC). Rev Esp Cardiol. 2022;75:429.

Achim

Stanek

Homorodean

Spinu

Onea

Lazăr

, et al. Approaches to peripheral artery disease in diabetes: are There any differences? Int J Environ Res Publ Health. 2022;19:9801.

Caruso

Maiorino

Longo

Porcellini

Matrone

Digitale Selvaggio

, et al. Liraglutide for lower limb perfusion in people with type 2 diabetes and peripheral artery disease: the STARDUST randomized clinical trial. JAMA Netw Open. 2024;7:e241545.

Butt

Kondo

Yang

Jhund

Docherty

Vaduganathan

, et al. Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER. Eur Heart J 2023; 44: 2170-2183. Erratum in: Eur Heart J. 2023; 44(29): 2681.

Marchiori

Rodionov

Peters

Magnussen

Nordanstig

Gombert

, et al. SGLT2 inhibitors and peripheral vascular Events: a review of the literature. Heart Fail Clin. 2022;18:609-623.

Sohn

Lim

. The role of cilostazol, a phosphodiesterase-3 inhibitor, in the development of atherosclerosis and vascular biology: a review with meta-analysis. Int J Mol Sci 2024; 25: 2593.

Gornik

Aronow

Goodney

Arya

Brewster

Byrd

, et al. Writing Committee Members, 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2024;83:2497-2604.